Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD–Dependent Manner

Overview of attention for article published in Molecular Cancer Therapeutics, May 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 1 X user

patent: 5 patents

Readers on

mendeley: 55 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Combination therapies comprising schweinfurthin compounds for treating cancer

Grant US-12427133-B2

United States of America

30 Sep 2025

SCHWEINFURTHINS AND USES THEREOF

Application EP-3375441-A1

European Patent Office

19 Sep 2018

Schweinfurthin analogues

Grant US-9428493-B2

United States of America

30 Aug 2016

Schweinfurthins and uses thereof

Grant US-8686016-B2

United States of America

01 Apr 2014

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.